Early Detection and Treatment of Alzheimer’s Disease and Dementia

Presented by Raj C. Shah, MD, Professor, Department of Family & Preventive Medicine and the Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL

Support: Funding for this Alzheimer’s Disease Early Detection Physician Training educational activity made possible by a grant from the Illinois Department of Public Health.

Learning Objectives

1.Understand the barriers associated with effective early diagnosis and treatment of Alzheimer’s disease and dementia

2.Identify the key component of a comprehensive cognitive evaluation

3.Highlight treatment and research options for individuals with cognitive concerns and their families

Accreditation
The Illinois Academy of Family Physicians (IAFP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Online Enduring Credit Designation:

AMA PRA Category 1 - The Illinois Academy of Family Physicians designates this online enduring material for a maximum of 1 AMA PRA Category 1 credit™

Faculty Disclosure Statement
The Illinois Academy of Family Physicians adheres to the conflict-of-interest policy of the ACCME and the AMA. It is the policy of Illinois AFP to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All individuals in a position to control the content in our programs are expected to disclose any relationships they may have with  commercial companies whose products or services may be mentioned so that participants may evaluate the objectivity of  the  presentations. In addition, any discussion of off-label, experimental, or investigational use of drugs or devices will be disclosed by the faculty. Only those participants who have no conflict of interest or who agree to an identified resolution process prior to their participation were involved in the CME activity.

Speaker & Faculty Disclosures

Dr. Shah reports being the site principal investigator or sub-investigator for Alzheimer’s disease clinical trials for which his institution (Rush University Medical Center) is compensated [Amylyx Pharmaceuticals, Inc., Athira Pharma, Inc., Edgewater NEXT, Eli Lilly & Co., Inc., and Genentech, Inc.]. Peer review of content prior to this activity has ensure evidence-based content using best available, highest strength of evidence. This presentation has been found to be without bias, and there is no conflict of interest for Dr. Shah to present this information.

Kate Valentine & Desma Rozovics (IAFP Staff) disclosed no relevant financial relationship or interest with a proprietary entity producing, marketing, reselling or distributing health care goods or services.